AIG
SRPT icon

American International Group’s Sarepta Therapeutics SRPT Stock Holding History

American International Group’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,492
Closed -$193K – 2360
2024
Q1 		$193K Sell
1,492
-21
-1% -$2.57K ﹤0.01% 2167
2023
Q4 		$146K Sell
1,513
-42
-3% -$4.03K ﹤0.01% 2346
2023
Q3 		$188K Sell
1,555
-108
-6% -$12.2K ﹤0.01% 2161
2023
Q2 		$190K Buy
1,663
+411
+33% +$53K ﹤0.01% 2200
2023
Q1 		$173K Sell
1,252
-37
-3% -$4.8K ﹤0.01% 2198
2022
Q4 		$167K Sell
1,289
-29
-2% -$3.36K ﹤0.01% 2229
2022
Q3 		$146K Buy
1,318
+4
+0.3% +$403 ﹤0.01% 2344
2022
Q2 		$98K Sell
1,314
-267
-17% -$19.6K ﹤0.01% 2611
2022
Q1 		$124K Hold
1,581
– – ﹤0.01% 2503
2021
Q4 		$142K Buy
1,581
+82
+5% +$7.01K ﹤0.01% 2556
2021
Q3 		$139K Sell
1,499
-114
-7% -$8.78K ﹤0.01% 2643
2021
Q2 		$125 Sell
1,613
-76
-4% -$5.76K ﹤0.01% 2786
2021
Q1 		$126 Sell
1,689
-202
-11% -$18.6K ﹤0.01% 2590
2020
Q4 		$322 Sell
1,891
-56
-3% -$8.3K ﹤0.01% 2012
2020
Q3 		$273K Sell
1,947
-89
-4% -$13.5K ﹤0.01% 1944
2020
Q2 		$326K Buy
2,036
+431
+27% +$58.7K ﹤0.01% 1829
2020
Q1 		$157K Sell
1,605
-50
-3% -$5.71K ﹤0.01% 2043
2019
Q4 		$214K Sell
1,655
-70
-4% -$7.07K ﹤0.01% 2178
2019
Q3 		$130K Hold
1,725
– – ﹤0.01% 2444
2019
Q2 		$262K Buy
1,725
+175
+11% +$21.3K ﹤0.01% 2060
2019
Q1 		$185K Sell
1,550
-55
-3% -$7.07K ﹤0.01% 2251
2018
Q4 		$175K Buy
1,605
+109
+7% +$13.6K ﹤0.01% 2260
2018
Q3 		$242K Hold
1,496
– – ﹤0.01% 2317
2018
Q2 		$198K Sell
1,496
-37,569
-96% -$3.54M ﹤0.01% 2355
2018
Q1 		$2.89M Sell
39,065
-2,101
-5% -$140K 0.01% 893
2017
Q4 		$2.29M Buy
41,166
+1,522
+4% +$80.6K 0.01% 967
2017
Q3 		$1.8M Buy
39,644
+7,411
+23% +$296K 0.01% 1032
2017
Q2 		$1.09M Buy
32,233
+1,863
+6% +$60.7K ﹤0.01% 1242
2017
Q1 		$899K Buy
30,370
+5,796
+24% +$179K ﹤0.01% 1254
2016
Q4 		$674K Sell
24,574
-64
-0.3% -$2.57K ﹤0.01% 1458
2016
Q3 		$1.51M Buy
24,638
+37
+0.2% +$1.12K 0.01% 1008
2016
Q2 		$469K Sell
24,601
-9,553
-28% -$177K ﹤0.01% 1622
2016
Q1 		$667K Buy
34,154
+2,733
+9% +$47.8K ﹤0.01% 1783
2015
Q4 		$1.21M Buy
31,421
+2,598
+9% +$84.2K 0.01% 1379
2015
Q3 		$925K Buy
28,823
+1,879
+7% +$63.8K ﹤0.01% 1520
2015
Q2 		$820K Sell
26,944
-994
-4% -$20.3K ﹤0.01% 1745
2015
Q1 		$371K Buy
27,938
+965
+4% +$12.9K ﹤0.01% 2418
2014
Q4 		$390K Sell
26,973
-439
-2% -$7.43K ﹤0.01% 2359
2014
Q3 		$578K Buy
27,412
+220
+0.8% +$4.96K ﹤0.01% 2002
2014
Q2 		$810K Buy
27,192
+1,054
+4% +$33.3K ﹤0.01% 1762
2014
Q1 		$628K Buy
26,138
+614
+2% +$15.7K ﹤0.01% 1898
2013
Q4 		$520K Buy
25,524
+3,251
+15% +$96.6K ﹤0.01% 2008
2013
Q3 		$1.05M Buy
22,273
+20,390
+1,083% +$785K 0.01% 1377
2013
Q2 		$71.6K Buy
+1,883
New +$67.3K ﹤0.01% 3374

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

American International Group's SRPT Position: Q2 2024 in Review

American International Group sold out of Sarepta Therapeutics (SRPT) in Q2 2024, closing a stake of 1,492 shares — an estimated $193K sold.

American International Group first reported a position in SRPT in Q2 2013 and held it in 44 quarters. The position peaked at $2.89M in Q1 2018. 483 funds tracked by Wall St. Rank hold SRPT as of Q2 2024.

  • American International Group reported no remaining Sarepta Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 1,492 Sarepta Therapeutics shares in Q2 2024, an estimated $193K.
  • American International Group first reported a position in Sarepta Therapeutics in Q2 2013 and held it in 44 quarters.
  • American International Group's Sarepta Therapeutics position peaked at $2.89M in Q1 2018.
  • 483 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.